News

Article

Beyond Awareness: Modeling Shared Decision-Making in Patient Communications

When patients struggle to see a positive path forward, modeling a constructive journey can give them the confidence they need.

When Coretta learned she had stage 4 non-small cell lung cancer, she was blindsided. She didn’t fit the profile. She didn’t see it coming. And she didn’t know what to do next. It’s a common experience in serious diagnoses—patients feel not just fear but paralysis. The problem? Coretta had never faced a challenge like this before. Would she have what it takes to get through it? Was there going to be anyone who could help guide her?

It’s for patients like herself that Coretta decided to participate in a novel format of patient storytelling: shared decision-making videos. These are authentic, dual-perspective narratives—videos where patients and their physicians tell the story together. Not a testimonial. Not a case study. A real story of how they met, how they collaborated, and how they decided what to do next.

A New Approach to Storytelling

In our work across various therapeutic areas, we’ve seen the power of this shift firsthand. A recent example comes from the oncology space: a video developed in partnership with Regeneron that features Coretta, a real patient, and her oncologist. Their story is told in parallel—each offering their perspective on the same moments, the same conversations, the same fears and decisions.

What makes this video stand out isn’t just the authenticity—it’s the intention. This isn’t another testimonial or success story. It’s a guide. And that’s a format we’re now beginning to expand into other categories, including mental health and rare disease, where patients often feel especially isolated or voiceless.

Why Modeling Works

Modeling is one of the oldest forms of learning—and one of the most effective. Don’t tell me, show me. Shared decision-making videos work because they:

  • Humanize the clinical: By showing real people navigating real conversations, they strip away the abstraction that often accompanies medical education.
  • Demystify engagement: They help patients understand what kinds of questions are okay to ask, what kind of information to expect, and how to actively participate in their care.
  • Normalize emotional response: By showing vulnerability from both patient and provider, they create space for viewers to acknowledge and process their own emotions.
  • Encourage relational trust: Seeing a physician listen, explain, and validate a patient’s concerns helps reinforce the idea that collaboration is not just possible—it’s the standard to expect.

Designing for Replicability

These videos work best when they’re accessible at the right moment in a patient’s journey: shortly after diagnosis, when options are being discussed, or when treatment decisions are on the horizon. For that reason, integrating them into brand websites, patient portals and care team conversations will help reaching the right people at the right time.

This isn’t about replacing other forms of patient education. It’s about filling a gap that has long been ignored—the gap between knowing and knowing how. Between information and action. Between being directed and having a guide.

Lessons for Marketers

The key take-aways from our experience are:

  1. Don’t just inform—model. Patients need to see what successful engagement looks like.
  2. Choose authentic storytellers. Real voices create trust that glossy campaigns can’t.
  3. Frame empowerment realistically. Show patients how to engage, not just that they should.

Healthcare marketing is evolving. So are patient expectations. In a landscape where trust is earned one interaction at a time, content that merely informs will no longer be enough. Content must connect, guide, and equip. Modeling shared decision-making is not a trend. It’s a necessary evolution—one that meets patients where they are and gives people like Coretta a clearer path forward.

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.